Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Undervalued and undersold

<< Previous

Bullboard Posts

Next >>

Comment by Lee430on Jan 13, 2023 7:58am

147 Views

Post# 35220555

RE:RE:RE:Undervalued and undersold

Sure looks like Thera's pieces are worh more than the whole at the moment as were at a Market Cap of just $97M....Seems like pocket change for a big player to take us out then carve it up like a holiday roast selling the slices off for a tidy profit...Frankly today I would bite on a low ball offer but probably regret it later.